Jeff Henretig

Jeff is the COO / CFO at Regalis, a high growth food distribution and CPG company and a Senior Advisor at EMKO Capital, a lower middle market private equity firm. Jeff was previously the CEO at Apothecanna, an industry leading CBD brand focused on bringing all-natural, plant-based remedies into the mainstream. Jeff joined Apothecanna in 2020 as President to foster the company's growth phase, leading to the sale of the business to HempFusion (TSX: CBDHF) in July 2021. Jeff was previously the CFO at Lord Jones, a celebrity favorite, luxury CBD brand where he was responsible for growth strategy, planning, analytics, budgeting and corporate development. During his tenure as CFO, Jeff led due diligence efforts in selling the brand to Cronos Group in 2019 (NASDAQ: CRON). Prior to Lord Jones, Jeff was Head of Finance & Operations at Verst, a software startup that was acquired by Dropbox in 2017. Jeff started his career in finance at Goldman Sachs where he was an analyst in the Private Equity Group within GSAM. He received his MBA in Entrepreneurship from the Wharton School at University of Pennsylvania and his BA in Psychology from Columbia University.

Jeff sees climate change as the #1 problem facing the world today and one that requires "full team" participation in reversing course - from new investment and business practices to political activism to large scale efforts to effect consumer behavior change - that's why he is more than excited to be joining the Vectors Capital team.